肝细胞生长素治疗活动性肝硬化近期临床疗效观察  

Clinical Observation of Hepatocyte Growth Factor in Treatment of Active Liver Cirrhosis

作　　者：刘明友[1] 李东[1] 耿玉凌[1] 陈焰[1] 

机构地区：[1]同济医科大学郧阳医学院附院传染科

出　　处：《同济医科大学郧阳医学院学报》1994年第1期21-24,共4页

摘　　要：采用肝细胞生长素（ＨＧＦ）治疗活动性肝硬化病人４２例，并与４０例同期同类型患者作对照，两组均采用传统综合护肝治疗，治疗组加用ＨＧＦ。结果发现治疗组有效率及症状、体征恢复时间肝功能指标变化都明显优于单用传统疗法。提示ＨＧＦ对活动性肝硬化确有良好疗效。Eighty-two patients of active liver cirrhosis were radomly treated with combined therapy of hepatocyte growth factor and traditional treatment,while the other forth patients were treated with traditional therapy as control group.The result showed that gross efffectious rate in study group was 85.7%;65.0% in control group(χ=8.05;P<0.01).It suggested that the hepatocyte growth factor was effective on the active liver cirrhosis.

关 键 词：肝细胞生长素 治疗 活动性肝硬化 疗效观察 

分 类 号：R575.2[医药卫生—消化系统]